Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$116.57

0.33 (0.28%)

06:33
05/22/19
05/22
06:33
05/22/19
06:33

Eli Lilly Insulin Lispro Injection now available for order in pharmacies

Eli Lilly's Insulin Lispro Injection is now available for order in pharmacies for people who use Lilly's insulin and need a lower-cost option. Lilly's Insulin Lispro Injection has a 50% lower list price than its identical medicine, Humalog U-100 and is available in both a vial and KwikPen. Because they are the same insulin, pharmacists will be able to substitute Insulin Lispro Injection for Humalog. In March, Lilly announced plans to introduce Insulin Lispro Injection, which fills another gap in the healthcare system. The people who are most likely to benefit from Insulin Lispro Injection are Medicare Part D beneficiaries, people with high-deductible health plans and the uninsured who use Humalog. Insulin Lispro Injection has a list price of $137.35 per vial and $265.20 for a package of five KwikPens. In addition to wholesaler contracts that have been secured, Lilly is working with payers to gain broad insurance coverage for Insulin Lispro Injection.

  • 30

    Jul

LLY Eli Lilly
$116.57

0.33 (0.28%)

04/18/19
PIPR
04/18/19
NO CHANGE
PIPR
Teva gains ground on Amgen in latest migraine survey, says Piper Jaffray
Following of survey of 99 neurologists done by his firm's partner Spherix Global Insights, Piper Jaffray analyst Christopher Raymond maintains an Overweight rating on Amgen (AMGN) and a Neutral rating on Teva Pharmaceutical (TEVA). The migraine survey indicates Eli Lilly's (LLY) Emgality is lagging and that Teva's Ajovy appears to be gaining ground on Amgen's Aimovig across numerous metrics, Raymond tells investors in a research note. While one data point does not a trend make, this move warrants close attention, especially given the increased significance assigned to Aimovig with respect to Amgen sentiment, says the analyst. Raymond, however, remains cautious on Teva shares given the" lack of clarity regarding when/where EBITDA will hit a trough." On the R&D side, the analyst notes that Overweight-rated Alder Biopharmaceuticals' (ALDR) eptinezumab "appears to be particularly top-of-mind among migraine specialists."
04/22/19
BMOC
04/22/19
NO CHANGE
Target $130
BMOC
Outperform
Eli Lilly price target lowered to $130 from $134 at BMO Capital
BMO Capital analyst Alex Arfaei lowered his price target on Eli Lilly to $130, saying the stock has underperformed along with its peers, and the news around its Tanezumab announced last week was "obviously negative". The analyst is keeping his Outperform rating however and believes that risk-reward on Eli Lilly is still "attractive" based on his "higher forecasts for Trulicity, Taltz, and Jardiance", as well as expectations around "improved margins". Arfaei adds that the company's upcoming REWIND data at the American Diabetes Association summit could be the "next major catalyst" for Eli Lilly shares.
04/23/19
EDJN
04/23/19
UPGRADE
EDJN
Buy
Eli Lilly upgraded to Buy from Hold at Edward Jones
Edward Jones analyst Ashtyn Evans upgraded Eli Lilly to Buy from Hold.
04/24/19
04/24/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Buy from Hold at Edward Jones. 2. Snap (SNAP) upgraded to In Line from Underperform at Evercore ISI and to Neutral from Underweight at JPMorgan. 3. Best Buy (BBY) upgraded to Buy from Hold at Jefferies with analyst Jonathan Matuszewski saying survey and data work suggest Best Buy's greater push toward services will drive long-term value and customer wallet share. 4. Procter & Gamble (PG) upgraded to Overweight from Equal Weight at Barclays with analyst Lauren Lieberman saying the market is shrugging off Procter & Gamble's 5% organic sales growth in its fiscal Q3, with many investors thinking this is the best it can get. 5. Sonoco (SON) upgraded to Buy from Hold at Argus with analyst David Coleman saying the stock has outperformed over the past 3 months, benefiting from its "accretive acquisitions, favorable pricing, improvements in productivity, and a lower effective tax rate." This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

GGB

Gerdau

$3.79

0.03 (0.80%)

13:40
06/19/19
06/19
13:40
06/19/19
13:40
Options
Massive 3way in Gerdau rolls short June 4 puts into long September combo »

Massive 3way in Gerdau…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

13:40
06/19/19
06/19
13:40
06/19/19
13:40
General news
Treasury Action: modest selling pressure has dominated in the bond market today »

Treasury Action: modest…

TEUM

Pareteum

$2.73

-0.085 (-3.02%)

13:39
06/19/19
06/19
13:39
06/19/19
13:39
Hot Stocks
Pareteum announces commercial launch of Pareteum Experience Cloud »

Pareteum Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 17

    Jul

GSK

GlaxoSmithKline

$40.51

0.28 (0.70%)

13:36
06/19/19
06/19
13:36
06/19/19
13:36
Periodicals
GlaxoSmithKline kicks off sale of $1.26B consumer health drugs, Reuters says »

GlaxoSmithKline has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 29

    Aug

GTE

Gran Tierra

$1.61

-0.325 (-16.80%)

13:28
06/19/19
06/19
13:28
06/19/19
13:28
Hot Stocks
Gran Tierra down 16% after saying it will revise guidance, issue with blockades »

In an earlier statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$40.52

0.29 (0.72%)

13:28
06/19/19
06/19
13:28
06/19/19
13:28
Periodicals
GlaxoSmithKline looks to raise GBP1B from portfolio disposals, Reuters says »

GlaxoSmithKline has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 29

    Aug

BYND

Beyond Meat

$166.15

-3.7 (-2.18%)

, YUM

Yum! Brands

$108.27

-0.42 (-0.39%)

13:25
06/19/19
06/19
13:25
06/19/19
13:25
Periodicals
Taco Bell not planning to add plant-based meat to its menu, CNBC says »

Yum Brands' (YUM)…

BYND

Beyond Meat

$166.15

-3.7 (-2.18%)

YUM

Yum! Brands

$108.27

-0.42 (-0.39%)

APO

Apollo Global

$33.92

0.485 (1.45%)

TACO

Del Taco

$11.37

-0.07 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$52.50

-0.38 (-0.72%)

, MSFT

Microsoft

$134.22

-0.98 (-0.72%)

13:25
06/19/19
06/19
13:25
06/19/19
13:25
On The Fly
Fly Intel: What to watch in Oracle's earnings report »

Oracle (ORCL) is…

ORCL

Oracle

$52.50

-0.38 (-0.72%)

MSFT

Microsoft

$134.22

-0.98 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 23

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

13:25
06/19/19
06/19
13:25
06/19/19
13:25
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

TOO

Teekay Offshore Partners

$1.15

0.02 (1.78%)

, BBU

Brookfield Business Partners

$39.47

1.54 (4.06%)

13:17
06/19/19
06/19
13:17
06/19/19
13:17
Hot Stocks
JDP says Brookfield Business offer for Teekay Offshore 'abusive, self-dealing' »

JDP Managing Partner…

TOO

Teekay Offshore Partners

$1.15

0.02 (1.78%)

BBU

Brookfield Business Partners

$39.47

1.54 (4.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/19/19
06/19
13:17
06/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/19/19
06/19
13:16
06/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$42.95

-0.27 (-0.62%)

13:15
06/19/19
06/19
13:15
06/19/19
13:15
Options
BNY Mellon put volume heavy and directionally bearish »

Bearish flow noted in BNY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

RIO

Rio Tinto

$59.44

-2.745 (-4.41%)

13:06
06/19/19
06/19
13:06
06/19/19
13:06
Hot Stocks
Rio Tinto drops over 4% after reporting operational challenges »

Earlier today, Rio Tinto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$116.95

0.28 (0.24%)

13:03
06/19/19
06/19
13:03
06/19/19
13:03
Hot Stocks
California American Water desalination project wins $10M state grant »

The California Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.62

-0.435 (-3.61%)

13:02
06/19/19
06/19
13:02
06/19/19
13:02
Hot Stocks
MGA calls off Mattel merger talks, says 'too much mess to clean up' »

MGA Entertainment CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$8.30

-0.045 (-0.54%)

13:01
06/19/19
06/19
13:01
06/19/19
13:01
Hot Stocks
Teva announces U.S. launch of generic version of Tracleer »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Z

Zillow

$45.36

-1.1 (-2.37%)

13:00
06/19/19
06/19
13:00
06/19/19
13:00
Options
Zillow put buyer opens new short-term position »

Zillow put buyer opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.62

-0.43 (-3.57%)

12:59
06/19/19
06/19
12:59
06/19/19
12:59
Hot Stocks
Breaking Hot Stocks news story on Mattel »

MGA Entertainment CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.24

0.14 (4.52%)

12:56
06/19/19
06/19
12:56
06/19/19
12:56
Hot Stocks
Sycamore Partners lowers takeover offer to Chico's to $3.00 per share »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$7.00

-0.09 (-1.27%)

12:55
06/19/19
06/19
12:55
06/19/19
12:55
Options
CymaBay put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.58

-0.47 (-3.90%)

12:55
06/19/19
06/19
12:55
06/19/19
12:55
Hot Stocks
Breaking Hot Stocks news story on Mattel »

MGA Entertainment says no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$23.93

0.57 (2.44%)

12:50
06/19/19
06/19
12:50
06/19/19
12:50
Periodicals
KKR close to selling partial stake in $2B helicopter firm, Bloomberg says »

According to Elffie Chew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.24

0.14 (4.52%)

12:49
06/19/19
06/19
12:49
06/19/19
12:49
Hot Stocks
Chico's erases gains after Bloomberg says Sycamore again lowered bid »

Chico's in midday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.25

0.145 (4.68%)

12:48
06/19/19
06/19
12:48
06/19/19
12:48
Periodicals
Sycamore Partners lowers bid for Chico's to $3 per share, Bloomberg reports »

Sycamore Partners has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.